Ameresco Board Director Francis V. Wisneski Jr. sold 10,000 Class A shares for approximately $303,000 on May 19, 2026, at $30.29 per share, reducing his direct holdings by 28.38%. The sale followed option exercise and was executed near prevailing market levels. Despite the insider sale, Wisneski received restricted stock units in June, maintaining a sizable equity stake of over 35,000 shares, suggesting continued confidence in the company.

Terra Innovatum Global (NASDAQ: NKLR), a micro-modular nuclear reactor developer, filed its first annual Form 10-K as a public company with $102.9 million in cash and a debt-free balance sheet. The company advanced NRC licensing milestones, selected Rock City Admiral Parkway in Illinois as its first-of-a-kind deployment site, and built a commercial pipeline of 100 SOLO units through non-binding MOUs. FY2025 operating loss was $33.7 million, but net income was $539.5 million primarily from non-cash gains on warrant liabilities.

Several stocks saw significant gains on Thursday, with Ameresco receiving a bullish upgrade from Jefferies, Lithium Americas experiencing potential government interest, and Kodiak Sciences getting an analyst upgrade.

Ameresco announced the acquisition of ASA Controls, which expands its portfolio in the smart buildings sector. The financial details of the acquisition have not been released, and Ameresco does not anticipate it will impact its 2025 fiscal results.

While some green energy stocks are charging higher, one lithium stock is the subject of considerable skepticism.

Ameresco (NYSE:AMRC) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 4 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 1 0 0 0 2M Ago 0 2 0 0 0 3M Ago 1 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Ameresco, presenting an average target of $34.12, a high estimate of $39.00, and a low estimate of $30.00. This current average represents a 9.93% decrease from the previous average price target of $37.88. Investigating Analyst Ratings: An Elaborate Study A clear picture of Ameresco's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target William Grippin UBS Raises Buy $39.00 $36.00 Stephen Gengaro Stifel Lowers Buy $32.00 $35.00 Ben Kallo Baird Raises Outperform $32.00 $28.00 Christopher Souther Truist Securities Lowers Buy $37.00 $40.00 Kashy Harrison Piper Sandler Lowers Overweight $30.00 $32.00 Pavel Molchanov Raymond James Lowers Outperform $35.00 $40.00 Kashy Harrison Piper Sandler Lowers Overweight $32.00 $42.00 George Gianarikas Canaccord Genuity Lowers Buy $36.00 $50.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ameresco. This information offers a snapshot ...Full story available on Benzinga.com

Ameresco (AMRC) delivered earnings and revenue surprises of 9.09% and 16.02%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Ormat Technologies (ORA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ameresco (AMRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In the last three months, 6 analysts have published ratings on Ameresco (NYSE:AMRC), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 3 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 2 0 0 0 2M Ago 1 1 0 0 0 3M Ago 1 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $35.0, a high estimate of $40.00, and a low estimate of $30.00. Experiencing a 16.01% decline, the current average is now lower than the previous average price target of $41.67. Diving into Analyst Ratings: An In-Depth Exploration A clear picture of Ameresco's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Christopher Souther Truist Securities Lowers Buy $37.00 $40.00 Kashy Harrison Piper Sandler Lowers Overweight $30.00 $32.00 Pavel Molchanov Raymond James Lowers Outperform $35.00 $40.00 Kashy Harrison Piper Sandler Lowers Overweight $32.00 $42.00 George Gianarikas Canaccord Genuity Lowers Buy $36.00 $50.00 Christopher Souther B. Riley Securities Lowers Buy $40.00 $46.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Ameresco. This ...Full story available on Benzinga.com

Ameresco (NYSE:AMRC) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $35.75, along with a high estimate of $40.00 and a low estimate of $32.00. Experiencing a 19.66% decline, the current average is now lower than the previous average price target of $44.50. Diving into Analyst Ratings: An In-Depth Exploration A comprehensive examination of how financial experts perceive Ameresco is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Pavel Molchanov Raymond James Lowers Outperform $35.00 $40.00 Kashy Harrison Piper Sandler Lowers Overweight $32.00 $42.00 George Gianarikas Canaccord Genuity Lowers Buy $36.00 $50.00 Christopher Souther B. Riley Securities Lowers Buy $40.00 $46.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ameresco. This ...Full story available on Benzinga.com

T, AMRC and AHCHY have been added to the Zacks Rank #5 (Strong Sell) List on March 6, 2023.